10/11/2019NHC: Chinese Patient Outcomes Improve Significantly

10/10/2019Innovent and Chi-Med to Evaluate Combo of Sintilimab and Surufatinib i...

10/10/2019China Introduces Policy to Boost Outpatient Reimbursement of Hypertens...

10/10/2019NHSA Introduces BMI Information Business Coding Standards

10/10/2019CDE Solicits Comments on Draft Dossier Requirements for Clinical Trial...

10/10/2019PwC: Biopharma M&As Remain Strong in China

10/9/2019More Chinese Challenge the Use of Traditional Treatments - They Want M...

10/9/2019Insilico Nabs $200M AI-powered Drug Discovery Deal with Chai Tai

10/9/2019The Lancet: China Is Winning Some Health-Care Battles - And Losing Oth...

10/9/2019Chinese Press Urges More Public Services to Care for Alzheimer's Patie...

10/8/2019MSD's KEYTRUDA Approved in First-Line Setting for NSCLC in China

10/3/2019CBMG Builds R&D Center in MD as Its ReJoin Stem Cell Therapy Accep...

10/2/2019NMPA Solicits Comments on the Provisions for Control of Drug Manufactu...

10/1/2019FiercePharma: Big Pharma CEOs' Chinese Names

10/1/2019Central Government Issues Implementation Opinions for Expanding 4+7 Tr...

9/30/2019Financial-related Company News in Brief

9/30/2019Central Government Issues New Policy for Healthcare Sector Development...

9/30/2019Chinese Health Authorities Pledge to Prioritize Rural Development

9/30/2019Erbitux 1L with FOLFOX or FOLFIRI Approved in China for RAS Wild-type ...

9/27/2019NHSA Sets Timeline for Phasing Out Provincial Level Additions of NRDL

9/27/2019Recent Executive Moves

9/27/2019NMPA Confirms Withdrawal of GMP and GSP Certifications, Pledging Timel...

9/26/2019As Tariffs Affect the Pharma Industry, Business Strategies Must Evolve

9/26/2019Thermo Fisher Scientific Expands Clinical Trials Capabilities and Anno...

9/26/2019Sanofi, AZ, Lilly and More Win Business in China's Expanded Cut-price ...

9/26/2019NHSA: BMI Reimbursed Nearly CNY 2B for 17 Anticancers in H1

9/25/2019NMPA Officially Joins IMDRF NCAR Exchange Program

9/24/2019Mitsubishi Tanabe Files for Tenelia (Teneligliptin) Approval in China

9/24/2019Helsinn and Mundipharma Jointly Announce NMPA's Approval of Oral Formu...

9/24/2019NMPA Co-sponsors 5th China-ASEAN Summit for Drug Development and Coope...

Page:108/334 Total number of articles:9993: [First][<<] [106] [107] [108] [109] [110] [>>] [End]